TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

CUSIP: 88338N206

Q4 2024 13F Holders as of 31 Dec 2024

Security identity
Security type / class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,676,558
Holder snapshot
Total 13F shares
3,528,745
Share change
+149,200
Total reported value
$3,034,778
Put/Call ratio
6.1%
Reported price per share
$0.86
Number of holders
38
Value change
+$127,744
Number of buys
8
Number of sells
9

Security key

88338N206

Report period

Q4 2024

Institutions

38

Top holders

10

TXMD full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 TherapeuticsMD, Inc. SEC filings TherapeuticsMD, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Clearline Capital LP
13D/G signal
Clearline Capital LP
Evidence rows
15
Latest as of
30 Sep 2024
13F 13D/G 3/4/5 Lead comparable stake: 5.5% 13D/G row: Clearline Capital LP Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Clearline Capital LP
13F 13D/G
Company
13F 13D/G
5.5%
from 13D/G
$1,056,793
636,622 shares
 — 30 Sep 2024
Rubric Capital Management LP
3/4/5 13F
Director, Other*, 10%+ Owner · Company
3/4/5 13F
10%
from 13F
$6,718,950
2,946,908 shares
 — 15 Nov 2023
Tejara Capital Ltd
13F
Company
13F
3.4%
$666,400
401,446 shares
 — 30 Sep 2024
VANGUARD GROUP INC
13F
Company
13F
3.3%
$643,386
387,582 shares
 — 30 Sep 2024
ADAR1 Capital Management, LLC
13F
Company
13F
2.3%
$448,466
270,160 shares
 — 30 Sep 2024
MORGAN STANLEY
13F
Company
13F
1.1%
$218,654
131,719 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
38
Shares
3,528,745
Rows available
38
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
34
Q4 2024 holders
38
Holder diff
4
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .